2015
DOI: 10.1016/j.vaccine.2015.05.009
|View full text |Cite
|
Sign up to set email alerts
|

Strangles in horses can be caused by vaccination with Pinnacle I. N.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 9 publications
0
11
0
Order By: Relevance
“…The intranasal mode of application should be such that an adequate amount of vaccine reaches the pharyngeal and lingual tonsils. Safety issues include residual virulence with formation of slowly developing mandibular abscesses in a proportion of vaccinates, nasal discharge, and occasional cases of immune‐mediated vasculitis (purpura). Since the vaccine contains live S. equi , accidental contamination of remote injection sites or metastatic (hematogenous/lymphatic) transfer from the pharynx will result in abscess formation at these locations.…”
Section: Vaccinationmentioning
confidence: 99%
“…The intranasal mode of application should be such that an adequate amount of vaccine reaches the pharyngeal and lingual tonsils. Safety issues include residual virulence with formation of slowly developing mandibular abscesses in a proportion of vaccinates, nasal discharge, and occasional cases of immune‐mediated vasculitis (purpura). Since the vaccine contains live S. equi , accidental contamination of remote injection sites or metastatic (hematogenous/lymphatic) transfer from the pharynx will result in abscess formation at these locations.…”
Section: Vaccinationmentioning
confidence: 99%
“…ST-395 is restricted to the Pinnacle IN live attenuated vaccine, which is produced by Zoetis. The CF32 strain (named USACF32 in Pathogenwatch), which was used as the basis of the Pinnacle IN vaccine [31], was attenuated by mutagenic treatment with N-methyl-N′-nitro-N-nitrosoguanidine (NTG), generating 68 point mutations, including two SNPs in spi that convert the allele 45 of ST-179 to allele 69 [10,32]. ST-395, therefore, represents an in vitro generated part of the MLST-defined population structure.…”
Section: Mlst Differentiates the S Equi Collection Into Six Sequencementioning
confidence: 99%
“…In this study, the vaccine strain was found to still be present in nasal swabs up to 36 days after vaccination and in tonsil swabs up to 46 days after vaccination which is potentially concerning because of the potential for reversion to virulence (Borst et al 2011). Cursons et al (2015) reported on a yearling filly and a 10 month-old filly that developed submandibular lymph node abscesses following vaccination with Pinnacle IN® (Zoetis, Florham Park, New Jersey).…”
Section: Commercially-available S Equi Vaccinesmentioning
confidence: 81%
“…The infecting strains were found to be similar to the vaccine strain through genome sequencing (Cursons et al 2015).…”
Section: Commercially-available S Equi Vaccinesmentioning
confidence: 99%